Lawful Access Framework
NPP allows for the coordinated import of life-saving medicines under specific regulatory provisions, ensuring patients benefit from global therapeutic innovations through the correct legal channels.
An Educational Overview of Named Patient Programs
The Named Patient Program (NPP) is a globally recognized regulatory pathway designed to enable patients to access specialty medicines that are not yet locally available or registered, based on a specific documentation-led request from their treating physician.
Aamrit supports process coordination and does not replace medical advice from your treating physician.
Who Utilizes the Pathway?
Typically relevant for oncology, rare diseases, and complex immunology cases where locally registered standard-of-care options have been exhausted or are not applicable for the clinical case.
Documentation Oversight
Every request is reviewed on a case-by-case basis. A valid prescription and clinical justification from a registered physician are the foundational requirements for compliance assessment.
01
Initial Inquiry
Patients or specialists initiate the request through our secure coordination portal.
04
Global Coordination
Connecting with verified global medicine providers for prescribed therapy sourcing.
The Pathway to Lawful Access
Aamrit provides a structured, documentation-led coordination process ensuring every request follows regulatory requirements.
*Availability depends on applicable laws, documentation review, and supplier responses.
02
Document Review
Thorough verification of medical prescriptions and supporting clinical documentation.
05
Regulatory Logictics
Managing complex import permits and customs coordination through lawful channels.
03
Pathway Assessment
Defining the legal access framework for the specialty therapy on a named-patient basis.
06
Supervised Delivery
Secure transit to the treating medical facility for designated patient administration.